By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioMimetic Pharmaceuticals, Inc. 

330 Mallory Station, Suite A-1

Franklin  Tennessee  37067  U.S.A.
Phone: 615-844-1280 Fax: 615-844-1281


Start Up

Company News
BioMimetic Pharmaceuticals, Inc. to Introduce Augmatrix™ Biocomposite Bone Graft Product Line at American Academy of Orthopaedic Surgeons 2/8/2012 7:40:24 AM
BioMimetic Pharmaceuticals, Inc. to Present at the Jefferies and Co. Global Healthcare Conference 6/6/2011 10:15:15 AM
BioMimetic Pharmaceuticals, Inc.'s Bone Product Trial Disappoints 10/14/2009 7:51:55 AM
BioMimetic Pharmaceuticals, Inc. Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures 10/29/2008 8:45:07 AM
BioMimetic Pharmaceuticals, Inc. Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1Bone Graft 6/7/2007 12:27:59 PM
The Week In Review: Big Week For IPOs 2/12/2007 1:48:53 PM
The Day In Review: SuperGen, Inc. (SUPG) Drug Disappoints 4/26/2006 6:10:46 PM
BioMimetic Therapeutics Initiates Clinical Trials With Novel Bio-Active Drug-Device Combination Bone Graft In Two Orthopedic Indications 3/20/2006 2:17:30 PM
BioMimetic Therapeutics Files For $50 Million IPO 2/10/2006 10:24:08 AM
BioMimetic Pharmaceuticals Inc. Raises $25.7 Million In Series C Financing10/19/2005 5:12:04 PM